A. Pauwels et al., SYSTEMIC ANTIBIOTIC-PROPHYLAXIS AFTER GASTROINTESTINAL HEMORRHAGE IN CIRRHOTIC-PATIENTS WITH A HIGH-RISK OF INFECTION, Hepatology, 24(4), 1996, pp. 802-806
In cirrhotic patients with gastrointestinal hemorrhage, bacterial infe
ctions are frequent and play a significant role in mortality. We have
previously found that patients with a Child-Pugh's class C or a reblee
ding are a subgroup of cirrhotic patients with a high risk of infectio
n. The aims of the study were (1) to validate these indicators and (2)
to assess the effectiveness of a systemic antibiotic treatment in pre
venting bacterial infections in bleeding cirrhotics with a high risk o
f infection. One hundred and nineteen bleeding cirrhotic patients were
divided into 3 groups. Patients with a Child-Pugh's class A-B and no
rebleeding (i.e., with a low risk of infection) constituted group 1 (n
= 55). Patients with a high risk of infection were randomly allocated
to serve as controls (group 2, n = 34) or to receive the ciprofloxaci
n and a combination of amoxicillin and clavulanic acid for 3 days afte
r hemorrhage (group 3, n = 30). This antibiotic prophylaxis was admini
stered first intravenously and then orally when the bleeding was contr
olled. The study period was defined as 10 days after hemorrhage. Incid
ence of bacterial infections was significantly higher in patients from
group 2 than in patients from group 1 (52.9% vs. 18.2%; P < .001). Mo
reover, infections were more severe in group 2: a sepsis syndrome or a
septic shock developed in 66.7% of infected patients from this group,
but in only 20% of infected patients from group 1. Incidence of bacte
rial infections was much lower in patients from group 3 than in those
from group 2 (13.3% vs. 52.9%; P < .001). Eight patients from group 2
(23.5%) and 4 patients from group 3 (13.3%) died during the first four
weeks (P-not significant). Septic shock was the cause of death in 3 p
atients from group 2 and in only 1 patient from group 3. The cost of a
ntibiotic therapy, including antibiotic prophylaxis in group 3, was $2
08 +/- $63 per patient in group 2 and $167 +/- $42 per patient in grou
p 3 (P < .05). We conclude that (1) patients with a Child-Pugh's class
C and/or a rebleeding are a subgroup of cirrhotic patients with a hig
h risk of infection after gastrointestinal hemorrhage and that (2) in
these patients, a prophylactic treatment with systemic antibiotics is
very effective in preventing bacterial infections.